Form 4 for CRL Charles River Laboratories
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-26 · accession 0001127602-23-017135 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-31 | 2023-05-27+ | CRL | Barbo William D | CCO, Corp. Executive VP | F - Tax | $194.12 | -480 | 10.2K | -5% | -$93.2K |
| D | 2023-05-31 | 2023-05-26 | CRL | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +1,958 | 10.4K | +23% | $0 |
| D | 2023-05-31 | 2023-05-26 | CRL | Barbo William D | CCO, Corp. Executive VP | A - Grant | $194.12 | +4,696 | 4,696 | New | +$911.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-29 | F | D | 202 | $194.12 | 9,954 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-26 | A | A | 1,958 | $0.00 | 10,434 | D | — | — | (F1) Restricted Stock Units vest as follows: 489 on May 26, 2024, 489 on May 26, 2025, 490 on May 26, 2026 and 490 on May 26, 2027. |
| 3 | Common | Common Stock | 2023-05-27 | F | D | 166 | $194.12 | 10,268 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-28 | F | D | 112 | $194.12 | 10,156 | D | — | — | |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-05-26 | A | A | 4,696 | $194.12 | 4,696 | D | $194.12 · 2024-05-26 to 2033-05-26 | 4,696 Common Stock | (F2) Stock Options vest as follows: 1,174 on May 26, 2024, 1,174 on May 26, 2025, 1,174 on May 26, 2026 and 1,174 on May 26, 2027. |